Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

RX

IMS Health (RX)

Ims Health, Inc.

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:RX

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
23/06/2011	22h13	Dow Jones News	2nd UPDATE: High Court Bars Labeling Lawsuits Vs Generic Drug Makers	NYSE:RX	Ims Health, Inc.
03/05/2010	22h43	Dow Jones News	Texas Fines Citigroup $130,000 For Failure To Report On Agent	NYSE:RX	Ims Health, Inc.
16/03/2010	23h49	Dow Jones News	UPDATE:Sen Kohl Probes Price Differences In Drugs In US, Abroad	NYSE:RX	Ims Health, Inc.
16/03/2010	22h52	Dow Jones News	Sen Kohl Probes Price Differences In Drugs Sold In US, Abroad	NYSE:RX	Ims Health, Inc.
16/03/2010	18h11	Dow Jones News	Emerging Markets To Make Half Of Pharma Sales Growth By '13 -Study	NYSE:RX	Ims Health, Inc.
09/03/2010	19h37	Edgar (US Regulatory)	Amended Statement of Ownership (SC 13G/A)	NYSE:RX	Ims Health, Inc.
08/03/2010	21h12	Edgar (US Regulatory)	Termination of Registration of a Class of Security under Section 12(b) (15-12B)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h33	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h30	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
03/03/2010	00h26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
02/03/2010	23h24	Edgar (US Regulatory)	Current report filing (8-K)	NYSE:RX	Ims Health, Inc.
02/03/2010	20h27	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
02/03/2010	20h26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
02/03/2010	20h26	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
02/03/2010	20h25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
02/03/2010	20h25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
02/03/2010	20h24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
02/03/2010	20h23	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
02/03/2010	20h20	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RX	Ims Health, Inc.
26/02/2010	20h52	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NYSE:RX	Ims Health, Inc.
26/02/2010	20h49	Edgar (US Regulatory)	Post-Effective Amendment to an S-8 filing (S-8 POS)	NYSE:RX	Ims Health, Inc.

Showing the most relevant articles for your search:NYSE:RX

1 2 3 4 5 6 7 8 9 10 Next >>

BNP Paribas (QX)

Financial Select Sector

Euro vs US Dollar

Deutsche Telekom

Deutsche Lufthansa

Invesco QQQ Trust Series 1

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen